ShankerValleau Wealth Advisors Inc. boosted its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 25.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,841 shares of the company’s stock after purchasing an additional 375 shares during the period. Procter & Gamble comprises 0.1% of ShankerValleau Wealth Advisors Inc.’s holdings, making the stock its 28th biggest holding. ShankerValleau Wealth Advisors Inc.’s holdings in Procter & Gamble were worth $309,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble in the 2nd quarter worth about $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble during the second quarter worth approximately $29,000. RPg Family Wealth Advisory LLC bought a new stake in shares of Procter & Gamble during the third quarter valued at approximately $33,000. Quest Partners LLC purchased a new stake in shares of Procter & Gamble in the second quarter valued at approximately $36,000. Finally, Fairfield Financial Advisors LTD bought a new position in Procter & Gamble in the second quarter worth approximately $44,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the sale, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock worth $13,317,460 over the last ninety days. Corporate insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Down 2.7 %
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same period last year, the business posted $1.83 EPS. The company’s revenue was down .6% on a year-over-year basis. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.51%. Procter & Gamble’s dividend payout ratio is currently 69.31%.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company upped their price target on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 22nd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research report on Monday, October 21st. Piper Sandler began coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Finally, Morgan Stanley boosted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $180.45.
Check Out Our Latest Stock Analysis on PG
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
- Five stocks we like better than Procter & Gamble
- 10 Best Airline Stocks to Buy
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- The How and Why of Investing in Gold Stocks
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- How Can Investors Benefit From After-Hours Trading
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.